Akanda Corp. (NASDAQ:AKAN) has closed the acquisition of Holigen Limited from The Flowr Corporation (TSXV:FLWR) (OTCPK:FLWPF), accelerating Akanda’s seed-to-patient business model in the EMEA region, improving the company’s ability to meet growing demand for medical cannabis and positioning it for adult use markets as regulations evolve.
“Holigen provides the added superior genetics, capacity, and route-to-market Akanda needs to ensure that we capture more than our share of the rapidly emerging cannabis market across the EMEA region,” stated Tej Virk, CEO of Akanda. “Together with Holigen, we are positioned to be a leader in today’s medical cannabis environment and to have the ability to scale to the recreational opportunity as it unfolds. Now that the acquisition has closed, I look forward with to working with Tom Flow and his team to leverage the platforms of both companies.”
